Flomics Biotech at ISLB 2026

Nov 7–9, 2026 Madrid, Spain ~700 attendees Website

Flomics Biotech brings 2 presentations to ISLB 2026 in Madrid. Its work centres on cell-free RNA in blood as a source of cancer signals. One study presents a cell-free RNA approach for early detection of colorectal cancer, and another uses ARdeNA to draw clinical insights from cell-free RNA.

OrganizationISLB 2026 Attendance
Flomics Biotech
Barcelona, Spain
flomics.com
Diagnostics & testing labs
Develops a cell-free RNA blood test for early cancer detection using sequencing and machine learning, and offers RNA sequencing and bioinformatics services.
Poster
Part of Poster sessions
A Robust Cell-free RNA Approach for the Early Detection of Colorectal Cancer
Early detection · New analytes
Poster
Part of Poster sessions
Cell-free RNA in Precision Medicine: Unlocking New Clinical Insights with ARdeNA
New analytes
Collaborators: Hospital Sant Joan de Déu Barcelona, University of Valencia

Explore the full ISLB 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ISLB 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Flomics Biotech

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the International Society of Liquid Biopsy (ISLB). Submit a correction